Krystal Biotech, Inc. (KRYS) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$48,571
Total Return
385.71%
CAGR
37.18%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.63% |
| Median | +1.49% |
| Best | +75.28% |
| Worst | -28.17% |
| % of Windows Positive | 55.7% |
1-Year (252 Trading Days)
| Average | +41.73% |
| Median | +41.61% |
| Best | +150.51% |
| Worst | -35.27% |
| % of Windows Positive | 86.3% |
3-Year (756 Trading Days)
| Average | +186.63% |
| Median | +183.23% |
| Best | +389.60% |
| Worst | +81.71% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -44.55% |
| Average Drawdown | -15.58% |
| Drawdown Duration | 343 Trading Days |
| Sortino Ratio | 1.54 |
| Calmar Ratio | 0.83 |
| CVaR (5%) | -7.13% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +22.42% (+61.58% ann.) | +$2242.23 | $0.00 | $0.00 | $0.00 |
| 2025 | +57.37% | +$5737.26 | $0.00 | $0.00 | $0.00 |
| 2024 | +26.28% | +$2627.76 | $0.00 | $0.00 | $0.00 |
| 2023 | +56.60% | +$5660.19 | $0.00 | $0.00 | $0.00 |
| 2022 | +13.25% | +$1325.23 | $0.00 | $0.00 | $0.00 |
| 2021 | +16.58% | +$1658.33 | $0.00 | $0.00 | $0.00 |
| 2020 | +8.34% | +$834.24 | $0.00 | $0.00 | $0.00 |
| 2019 | +166.51% | +$16650.62 | $0.00 | $0.00 | $0.00 |
| 2018 | +97.53% | +$9752.85 | $0.00 | $0.00 | $0.00 |
| 2017 partial | -1.13% (-4.06% ann.) | $112.78 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 20, 2017 – February 19, 2020 | +489.29% | +108.45% | +$48928.57 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -40.61% | -99.74% | $4061.01 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +4.53% | +7.38% | +$452.68 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +110.60% | +102.70% | +$11059.67 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -7.90% | -8.36% | $789.57 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +144.21% | +61.88% | +$14420.65 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +65.16% | +34.20% | +$6516.36 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.